Partners & Investors

Collaborating with AI-focused Biotech Partners

Led by experienced drug hunters with a track record of delivering the next generation of drugs for brain disorders, Blue Oak pursues new drug classes and drugs with its biotech partners, including leading experts in AI deep-behavioral modeling and AI-driven small molecule design.

NIMH Funding

Blue Oak has received sustained funding from the National Institute of Mental Health (NIMH) to support drug discovery and clinical development.

Strategic Partners

Exscientia
PsychoGenics
EuMentis

Investors

Shang Pharma innovation
IVA Biotech
JMCR Family Office
Sprout BioVentures
PsychoGenics

Research Partners

ChemPartner
PDSP
Certerra
Transpharmation
SB Drug Discovery
Porsolt

Join Our Fight Against Brain Disorders

For investment or partnership opportunities or to learn more about our clinical programs, contact our team today.

CONTACT US
caret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-square